The Korean Journal of Pain

  • 제35권1호
  • /
  • Pages.33-42
  • /
  • 2022
  • /
  • 2005-9159(pISSN)
  • /
  • 2093-0569(eISSN)
대한통증학회 (The Korean Pain Society)
권호 표지
DOI QR코드

DOI QR Code

Anti-nociceptive and anti-inflammatory activities of the essential oil isolated from Cupressus arizonica Greene fruits

  • Fakhri, Sajad (Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences) ;
  • Jafarian, Safoora (Student Research Committee, Kermanshah University of Medical Sciences) ;
  • Majnooni, Mohammad Bagher (Student Research Committee, Kermanshah University of Medical Sciences) ;
  • Farzaei, Mohammad Hosein (Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences) ;
  • Mohammadi-Noori, Ehsan (Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences) ;
  • Khan, Haroon (Department of Pharmacy, Abdul Wali Khan University Mardan)
  • 투고 : 2021.07.29
  • 심사 : 2021.09.11
  • 발행 : 2022.01.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Cupressus arizonica Greene is a coniferous tree with great importance in fragrance and pharmaceutical industries. Essential oils from C. arizonica (EC) have shown potential antioxidant, and anti-microbial activities. This study aimed at investigating the anti-nociceptive and anti-inflammatory effects/mechanisms of EC. Methods: The EC was evaluated for anti-nociceptive and anti-inflammatory activities on male Wistar rats using a formalin test and carrageenan-induced paw edema, respectively. Also, we pre-treated some of the animals with naloxone and flumazenil in the formalin test to find out the possible contributions of opioid and benzodiazepine receptors to EC anti-nociceptive effects. Finally, gas chromatography/mass spectrometry (GC/MS) analysis was used to identify the EC's constituents. Results: EC in intraperitoneal doses of 0.5 and 1 g/kg significantly decrease the nociceptive responses in both early and late phases of the formalin test. From a mechanistic point of view, flumazenil administration 20 minutes before the most effective dose of EC (1 g/kg) showed a meaningful reduction in the associated anti-nociceptive responses during the early and late phases of the formalin test. Naloxone also reduced the anti-nociceptive role of EC in the late phase. Furthermore, EC at the doses of 1, 0.5, and 0.25 g/kg significantly reduced paw edema from 0.5 hours after carrageenan injection to 4 hours. GC/MS analysis showed that isolated EC is a monoterpene-rich oil with the major presence of α-pinene (71.92%), myrcene (6.37%), δ-3-carene (4.68%), β-pinene (3.71%), and limonene (3.34%). Conclusions: EC showed potent anti-nociceptive and anti-inflammatory activities with the relative involvement of opioid and benzodiazepine receptors.

키워드

과제정보

S.F. thanks Dr. Fatemeh Abbaszadeh for comments and modifications on statistical analysis.

참고문헌

  1. Turk DC, Meichenbaum D, Genest M. Pain and behavioral medicine: a cognitive-behavioral perspective. New York, Guilford Press. 1983.
  2. Marazziti D, Mungai F, Vivarelli L, Presta S, Dell'Osso B. Pain and psychiatry: a critical analysis and pharmacological review. Clin Pract Epidemiol Ment Health 2006; 2: 31. https://doi.org/10.1186/1745-0179-2-31
  3. Fakhri S, Ahmadpour Y, Rezaei H, Kooshki L, Moradi SZ, Iranpanah A, et al. The antinociceptive mechanisms of melatonin: role of L-arginine/nitric oxide/cyclic GMP/KATP channel signaling pathway. Behav Pharmacol 2020; 31: 728-37. https://doi.org/10.1097/FBP.0000000000000579
  4. Fakhri S, Abbaszadeh F, Jorjani M. On the therapeutic targets and pharmacological treatments for pain relief following spinal cord injury: a mechanistic review. Biomed Pharmacother 2021; 139: 111563. https://doi.org/10.1016/j.biopha.2021.111563
  5. Woolf CJ. What is this thing called pain? J Clin Invest 2010; 120: 3742-4. https://doi.org/10.1172/JCI45178
  6. Singh BM, Negi G, Bhole P, Jaiprakash M. Pain and inflammation: a review. Int J Pharm Sci Res 2012; 3: 4697-709.
  7. McCleane G. Antidepressants as analgesics. CNS Drugs 2008; 22: 139-56. https://doi.org/10.2165/00023210-200822020-00005
  8. Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 2011; 115: 1363-81. https://doi.org/10.1097/aln.0b013e318238bba6
  9. Enna SJ, McCarson KE. The role of GABA in the mediation and perception of pain. Adv Pharmacol 2006; 54: 1-27. https://doi.org/10.1016/S1054-3589(06)54001-3
  10. Arome D, Sunday AI, Onalike EI, Amarachi A. Pain and inflammation: management by conventional and herbal therapy. Indian J Pain 2014; 28: 5-12. https://doi.org/10.4103/0970-5333.128879
  11. Rastegari-Pouyani M, Mostafaie A, Mansouri K, MortazaviJahromi SS, Mohammadi-Motlagh HR, Mirshafiey A. Antiangiogenesis effect of β-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive properties under experimental model. Clin Exp Pharmacol Physiol 2018; 45: 370-6. https://doi.org/10.1111/1440-1681.12907
  12. Deraedt R, Jouquey S, Delevallee F, Flahaut M. Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur J Pharmacol 1980; 61: 17-24. https://doi.org/10.1016/0014-2999(80)90377-5
  13. Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gogenur I. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res 2011; 51: 270-7. https://doi.org/10.1111/j.1600-079X.2011.00895.x
  14. Hassanpouraghdam MB. α-Pinene- and β-myrcene-rich volatile fruit oil of Cupressus arizonica Greene from northwest Iran. Nat Prod Res 2011; 25: 634-9. https://doi.org/10.1080/14786419.2010.531479
  15. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161-74. https://doi.org/10.1016/0304-3959(77)90130-0
  16. Pandpazir M, Kiani A, Fakhri S, Mousavi Z. Anti-inflammatory effect and skin toxicity of aqueous extract of Dorema ammoniacum gum in experimental animals. Res J Pharmacogn 2018; 5: 1-8.
  17. Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol 2003; 225: 115-21.
  18. Adams RP. Identification of essential oil components by gas chromatography/quadrupole mass spectroscopy. 3rd ed. Carol Stream, Allured Publishing Corp. 2001.
  19. Babushok VI, Linstrom PJ, Zenkevich IG. Retention indices for frequently reported compounds of plant essential oils. J Phys Chem Ref Data 2011; 40: 043101. https://doi.org/10.1063/1.3653552
  20. Moradi N, Fakhri S, Farzaei MH, Abbaszadeh F. The anti-nociceptive activity of naringenin passes through L-arginine/NO/cGMP/KATP channel pathway and opioid receptors. Behav Pharmacol 2021; 32: 590-8. https://doi.org/10.1097/FBP.0000000000000653
  21. Taherian AA, Etemadi H, Sadeghi H. Assessment of aqueous extract of seed of Cuminum cyminum L. on neurogenic and inflammatory pain in mice. J. Med. Plants 2007; 6: 44-50.
  22. Morteza-Semnani K, Saeedi M, Hamidian M, Vafamehr H, Dehpour AR. Anti-inflammatory, analgesic activity and acute toxicity of Glaucium grandiflorum extract. J Ethnopharmacol 2002; 80: 181-6. https://doi.org/10.1016/S0378-8741(02)00027-2
  23. Popovic V, Petrovic S, Tomic M, Stepanovic-Petrovic R, Micov A, Pavlovic-Drobac M, et al. Antinociceptive and anti-edematous activities of the essential oils of two Balkan endemic Laserpitium species. Nat Prod Commun 2014; 9: 125-8.
  24. Emami SA, Fakhrjafary M, Tafaghodi M, Hassanzadeh MK. Chemical composition and antioxidant activities of the essential oils of different parts of Cupressus arizonica Greene. J Essent Oil Res 2010; 22: 193-9. https://doi.org/10.1080/10412905.2010.9700301
  25. Flamini G, Cioni PL, Morelli I, Bighelli A, Castola V, Casanova J. GC/MS and 13C-NMR integrated analyses of the essential oils from leaves, branches and female cones of Cupressus arizonica from Italy. J Essent Oil Res 2003; 15: 302-4. https://doi.org/10.1080/10412905.2003.9698596
  26. Biswas SK. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid Med Cell Longev 2016; 2016: 5698931. https://doi.org/10.1155/2016/5698931
  27. Masotti V, Juteau F, Bessiere JM, Viano J. Seasonal and phenological variations of the essential oil from the narrow endemic species Artemisia molinieri and its biological activities. J Agric Food Chem 2003; 51: 7115-21. https://doi.org/10.1021/jf034621y
  28. Cheraif I, Jannet HB, Hammami M, Khouja ML, Mighri Z. Chemical composition and antimicrobial activity of essential oils of Cupressus arizonica Greene. Biochem Syst Ecol 2007; 35: 813-20. https://doi.org/10.1016/j.bse.2007.05.009
  29. Dragomanova S, Tancheva L, Georgieva M, Klisurov R. Analgesic and anti-inflammatory activity of monoterpenoid Myrtenal in rodents. J IMAB 2019; 25: 2406-13. https://doi.org/10.5272/jimab.2019251.2406
  30. Kim DS, Lee HJ, Jeon YD, Han YH, Kee JY, Kim HJ, et al. Alpha-pinene exhibits anti-inflammatory activity through the suppression of MAPKs and the NF-κB pathway in mouse peritoneal macrophages. Am J Chin Med 2015; 43: 731-42. https://doi.org/10.1142/S0192415X15500457
  31. Rufino AT, Ribeiro M, Judas F, Salgueiro L, Lopes MC, Cavaleiro C, et al. Anti-inflammatory and chondroprotective activity of (+)-α-pinene: structural and enantiomeric selectivity. J Nat Prod 2014; 77: 264-9. https://doi.org/10.1021/np400828x
  32. Him A, Ozbek H, Turel I, Oner AC. Antinociceptive activity of alpha-pinene and fenchone. Pharmacologyonline 2008; 3: 363-9.
  33. Orhan I, Kupeli E, Aslan M, Kartal M, Yesilada E. Bioassayguided evaluation of anti-inflammatory and antinociceptive activities of pistachio, Pistacia vera L. J Ethnopharmacol 2006; 105: 235-40. https://doi.org/10.1016/j.jep.2005.10.023
  34. Guimaraes AG, Quintans JS, Quintans LJ Jr. Monoterpenes with analgesic activity--a systematic review. Phytother Res 2013; 27: 1-15. https://doi.org/10.1002/ptr.4686
  35. Yoon WJ, Lee NH, Hyun CG. Limonene suppresses lipopolysaccharide-induced production of nitric oxide, prostaglandin E2, and pro-inflammatory cytokines in RAW 264.7 macrophages. J Oleo Sci 2010; 59: 415-21. https://doi.org/10.5650/jos.59.415